A nurse is assisting in the care of a client who has HELLP syndrome and needs a magnesium sulfate infusion.
Which of the following reasons should the nurse identify as the primary purpose of administering magnesium sulfate?

Choice A rationale

The primary purpose of administering magnesium sulfate in HELLP syndrome and preeclampsia is to reduce cerebral vasospasm and provide neuroprotection to prevent eclamptic seizures. Magnesium acts as a calcium channel blocker and a central nervous system depressant, increasing the seizure threshold. It relaxes the smooth muscles of the cerebral blood vessels, improving blood flow and reducing the risk of neurological injury. This is the gold standard for seizure prophylaxis in hypertensive disorders of pregnancy.

Choice B rationale

While magnesium sulfate has a mild vasodilatory effect, it is not used as a primary antihypertensive agent to stabilize or lower blood pressure. It is often administered concurrently with actual antihypertensives like labetalol or hydralazine. If the nurse monitors the blood pressure and sees a significant drop, it is usually a secondary effect rather than the intended pharmacological goal. The focus of magnesium therapy remains the prevention of seizures rather than the management of hypertension.

Choice C rationale

Enhancing fetal lung maturity is the role of corticosteroids like betamethasone or dexamethasone, which stimulate surfactant production in the fetal lungs. Magnesium sulfate does not have this effect. While magnesium may be used for fetal neuroprotection in very early preterm births to reduce the risk of cerebral palsy, its primary indication in a mother with HELLP syndrome is specifically to protect the mother from developing life-threatening eclamptic seizures during the peripartum period.

Choice D rationale

Magnesium sulfate does not increase urine output; in fact, it is primarily excreted by the kidneys, and adequate urine output is required to prevent magnesium toxicity. A common sign of toxicity is decreased urine output (less than 30 mL/hr), as the drug accumulates in the blood when renal function is impaired. Normal magnesium therapeutic levels are 4 to 7 mEq/L. The nurse must monitor intake and output closely to ensure the client is clearing the medication safely. .

Choice A rationale

While a healthy diet is generally recommended during pregnancy, restricting high-sugar foods is not a specific primary intervention for managing gestational hypertension unless the client also has concurrent gestational diabetes. The focus in hypertension is on monitoring blood pressure, detecting protein in the urine, and observing for signs of preeclampsia. While nutrition is important for overall health, sugar intake does not have a direct, evidence-based causal link to the immediate stabilization of hypertensive blood pressure readings.

Choice B rationale

Encouraging a client with gestational hypertension to begin an evening walking regimen is inappropriate and potentially harmful. In the management of hypertensive disorders of pregnancy, providers typically recommend activity restriction or modified bed rest rather than starting new exercise routines. Physical exertion can further elevate blood pressure and increase the risk of transitioning from gestational hypertension to preeclampsia or eclampsia. Rest is prioritized to maximize uteroplacental perfusion and minimize systemic stress on the maternal cardiovascular system.

Choice C rationale

Monitoring weight gain is a critical health promotion recommendation for clients with gestational hypertension. Rapid weight gain, often defined as more than 2 pounds or 0.9 kg in a single week, can be an early clinical sign of fluid retention and the development of edema. This often precedes more severe manifestations of preeclampsia. Regular weighing allows the client and healthcare provider to track fluid status and intervene early if sudden shifts suggest worsening systemic vascular permeability.

Choice D rationale

Limiting caffeine to 400 mg per day is incorrect because the standard recommendation for pregnant individuals is to limit caffeine to less than 200 mg per day. Caffeine is a stimulant that can cause vasoconstriction and transient increases in blood pressure, which is counterproductive in a client already experiencing hypertension. High intake may also affect fetal growth. Therefore, recommending a 400 mg limit provides a false sense of safety for a dose that is actually too high.

Choice E rationale

Taking a magnesium supplement for headaches is an unsafe recommendation. Headaches in a client with gestational hypertension are "red flag" symptoms that may indicate the onset of preeclampsia or worsening neurological irritability. These symptoms require immediate medical evaluation rather than self-medication. Furthermore, while magnesium sulfate is used in the hospital to prevent seizures in preeclampsia, oral magnesium supplements are not a recognized or effective treatment for hypertensive headaches during pregnancy and could delay necessary care.

Choice F rationale

Attending all prenatal visits is essential for the safe management of gestational hypertension. Frequent monitoring allows healthcare providers to assess blood pressure trends, perform urinalysis for protein, and monitor fetal well-being through non-stress tests or biophysical profiles. Because gestational hypertension can progress rapidly to preeclampsia, consistent surveillance is the most effective way to identify complications early, manage symptoms, and determine the optimal timing for delivery to ensure the safety of both mother and infant.